Skip to main content
Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.910
+0.340 (9.52%)
At close: Nov 13, 2026, 4:00 PM EST
3.920
+0.010 (0.26%)
After-hours: Nov 13, 2026, 7:59 PM EST

Aquestive Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
48.8444.5557.5650.5847.6850.83
Revenue Growth
12.53%-22.61%13.79%6.09%-6.20%10.87%
Gross Profit
31.9125.9939.6929.7528.2935.84
Operating Income
-55.74-71.05-30.77-15.1-42.07-34.68
Net Income
-79.28-83.78-44.14-7.87-54.41-70.54
Earnings Per Share
-0.64-0.78-0.51-0.13-1.12-1.85
EPS Growth
------

Revenue by Geography
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
38.2429.639.9337.140.7942.86
Ex-United States
10.614.9417.6313.486.897.97
Total
48.8444.5557.5650.5847.6850.83

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
90.35121.1771.5523.8727.2728.02
Total Debt
58.7742.483833.3257.4956.42
Net Cash (Debt)
31.5878.6933.54-9.45-30.22-28.4
Net Cash Growth
-63.99%134.59%----
Net Cash Per Share
0.260.740.39-0.15-0.62-0.75

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-39.76-52.43-35.76-6.38-9.82-32.98
Capital Expenditures
-0.93-0.56-0.16-1-1.02-0.91
Free Cash Flow
-40.7-52.99-35.92-7.38-10.84-33.89
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
65.34%58.34%68.95%58.82%59.34%70.51%
Operating Margin
-114.13%-159.50%-53.46%-29.86%-88.23%-68.22%
Pretax Margin
-162.33%-188.09%-76.70%-15.07%-114.11%-138.77%
Profit Margin
-162.33%-188.09%-76.68%-15.56%-114.12%-138.77%
FCF Margin
-83.33%-118.97%-62.40%-14.58%-22.74%-66.67%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.0617.695.642.671.023.07